| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
257,668 |
234,632 |
$39.33M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
177,333 |
157,992 |
$33.27M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
85,577 |
65,292 |
$28.81M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
77,068 |
67,145 |
$16.45M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
75,605 |
69,418 |
$9.06M |
| 70450 |
Computed tomography, head or brain; without contrast material |
27,828 |
23,644 |
$7.44M |
| J2350 |
Injection, ocrelizumab, 1 mg |
311 |
258 |
$6.62M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
19,536 |
16,192 |
$6.13M |
| G0378 |
Hospital observation service, per hour |
61,415 |
26,656 |
$5.07M |
| J9271 |
Injection, pembrolizumab, 1 mg |
522 |
345 |
$4.46M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12,772 |
10,431 |
$3.02M |
| J2323 |
Injection, natalizumab, 1 mg |
574 |
499 |
$2.90M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16,980 |
11,735 |
$2.56M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
8,322 |
6,816 |
$2.42M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
10,307 |
8,018 |
$2.33M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,628 |
4,487 |
$2.21M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15,989 |
11,926 |
$2.14M |
| 93976 |
|
7,230 |
5,855 |
$1.12M |
| 27447 |
|
449 |
320 |
$1.04M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
107,141 |
83,173 |
$1.04M |
| 70496 |
|
3,253 |
2,649 |
$1.04M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,087 |
3,730 |
$894K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,042 |
4,070 |
$883K |
| 70498 |
|
5,695 |
4,560 |
$802K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,790 |
2,385 |
$781K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
119,529 |
102,141 |
$731K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
86,040 |
65,391 |
$715K |
| 59025 |
Fetal non-stress test |
4,189 |
2,833 |
$697K |
| 47562 |
|
200 |
172 |
$629K |
| 80053 |
Comprehensive metabolic panel |
65,284 |
53,570 |
$624K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,393 |
3,641 |
$623K |
| 96415 |
|
2,299 |
1,642 |
$608K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,228 |
2,661 |
$571K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,271 |
5,569 |
$527K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,469 |
2,327 |
$526K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
2,820 |
1,845 |
$502K |
| 62323 |
|
1,007 |
888 |
$458K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
11,889 |
9,881 |
$457K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
26,237 |
22,811 |
$452K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
64,479 |
41,670 |
$446K |
| 70491 |
|
1,419 |
1,104 |
$437K |
| 0240U |
|
3,185 |
2,763 |
$432K |
| 82805 |
|
13,206 |
10,723 |
$423K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
975 |
840 |
$417K |
| 36415 |
Collection of venous blood by venipuncture |
260,171 |
204,812 |
$417K |
| 20680 |
|
316 |
248 |
$416K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,306 |
2,888 |
$409K |
| 71046 |
Radiologic examination, chest; 2 views |
36,508 |
32,979 |
$405K |
| 71045 |
Radiologic examination, chest; single view |
62,807 |
54,813 |
$402K |
| 27130 |
|
106 |
79 |
$400K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,365 |
1,194 |
$398K |
| 84484 |
|
56,020 |
44,229 |
$364K |
| 74174 |
|
4,387 |
3,468 |
$346K |
| 83605 |
|
48,485 |
39,723 |
$339K |
| 29827 |
|
145 |
113 |
$318K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,842 |
2,508 |
$317K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,420 |
1,198 |
$316K |
| 76642 |
|
2,024 |
1,808 |
$299K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
87,143 |
74,948 |
$295K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,312 |
2,113 |
$294K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,196 |
1,788 |
$294K |
| 64415 |
|
759 |
568 |
$290K |
| 10060 |
|
1,676 |
1,409 |
$281K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
204 |
179 |
$277K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,182 |
2,664 |
$275K |
| 96367 |
|
3,478 |
2,224 |
$269K |
| 93458 |
|
238 |
176 |
$265K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
256,646 |
218,231 |
$263K |
| 93971 |
|
3,188 |
2,747 |
$255K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15,185 |
12,720 |
$251K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
442 |
402 |
$251K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
906 |
813 |
$238K |
| 93970 |
|
1,397 |
1,178 |
$237K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,347 |
1,190 |
$229K |
| 12001 |
|
1,372 |
1,212 |
$227K |
| 93922 |
|
2,623 |
2,367 |
$223K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,903 |
4,037 |
$217K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,299 |
1,300 |
$206K |
| 64447 |
|
601 |
427 |
$205K |
| 86900 |
|
8,759 |
6,958 |
$197K |
| 93925 |
|
1,558 |
1,456 |
$196K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,482 |
3,155 |
$195K |
| 11045 |
|
492 |
330 |
$186K |
| 96376 |
|
15,233 |
8,348 |
$184K |
| 75574 |
|
668 |
546 |
$181K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
948 |
795 |
$172K |
| 72131 |
|
2,805 |
2,311 |
$171K |
| 58661 |
|
71 |
42 |
$171K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,948 |
1,314 |
$165K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
803 |
783 |
$161K |
| J3490 |
Unclassified drugs |
26,100 |
15,630 |
$161K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
44,704 |
40,653 |
$156K |
| 71250 |
|
2,076 |
1,760 |
$155K |
| 72141 |
|
868 |
752 |
$151K |
| 72197 |
|
514 |
460 |
$149K |
| 73221 |
|
611 |
557 |
$148K |
| 12011 |
|
846 |
746 |
$145K |
| 70486 |
|
2,732 |
2,251 |
$140K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
574 |
512 |
$137K |
| 72100 |
|
4,637 |
3,949 |
$128K |
| 73130 |
|
6,474 |
5,473 |
$124K |
| 71271 |
|
634 |
587 |
$124K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,126 |
1,734 |
$119K |
| 93017 |
|
1,280 |
1,104 |
$118K |
| 73560 |
|
7,575 |
6,315 |
$116K |
| 19083 |
|
127 |
108 |
$112K |
| 80320 |
|
6,160 |
5,652 |
$110K |
| J1756 |
Injection, iron sucrose, 1 mg |
3,269 |
1,370 |
$109K |
| 97116 |
|
2,885 |
1,536 |
$107K |
| 29881 |
|
79 |
52 |
$105K |
| 74183 |
|
372 |
329 |
$104K |
| 84703 |
|
80,182 |
70,125 |
$102K |
| 73030 |
|
5,263 |
4,353 |
$100K |
| 52356 |
|
59 |
41 |
$99K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
65,583 |
48,886 |
$99K |
| 64450 |
|
312 |
226 |
$98K |
| 70487 |
|
308 |
248 |
$96K |
| 99215 |
Prolong outpt/office vis |
1,005 |
764 |
$95K |
| 76536 |
|
723 |
657 |
$92K |
| 12002 |
|
646 |
548 |
$92K |
| 76801 |
|
3,297 |
2,634 |
$91K |
| 64721 |
|
71 |
68 |
$91K |
| 73700 |
|
728 |
623 |
$91K |
| 76830 |
Ultrasound, transvaginal |
3,271 |
2,702 |
$87K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
672 |
445 |
$86K |
| 86850 |
|
8,496 |
6,706 |
$86K |
| 94660 |
|
1,004 |
449 |
$80K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,724 |
2,153 |
$80K |
| 83880 |
|
11,899 |
9,597 |
$80K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
345 |
317 |
$79K |
| 94060 |
|
648 |
565 |
$79K |
| 72128 |
|
1,712 |
1,387 |
$77K |
| 81001 |
|
111,673 |
99,703 |
$77K |
| 80047 |
|
24,750 |
20,918 |
$76K |
| 88307 |
|
653 |
503 |
$74K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,223 |
3,048 |
$74K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,285 |
788 |
$73K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15,714 |
13,141 |
$72K |
| 87506 |
|
556 |
441 |
$72K |
| 82077 |
|
15,669 |
12,488 |
$71K |
| 73630 |
|
6,333 |
5,418 |
$70K |
| 90715 |
|
3,613 |
2,990 |
$69K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
116 |
88 |
$69K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20,525 |
17,717 |
$69K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,906 |
9,131 |
$68K |
| 76820 |
|
701 |
430 |
$67K |
| 76821 |
|
680 |
384 |
$67K |
| 36591 |
|
1,775 |
880 |
$66K |
| 97166 |
|
1,620 |
1,221 |
$66K |
| 97162 |
|
1,950 |
1,517 |
$64K |
| 29824 |
|
237 |
172 |
$63K |
| 80051 |
|
29,162 |
24,966 |
$62K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
57 |
50 |
$61K |
| 29826 |
|
210 |
152 |
$61K |
| 82248 |
|
41,578 |
35,457 |
$61K |
| 72050 |
|
1,442 |
1,227 |
$61K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
815 |
656 |
$59K |
| 29879 |
|
57 |
52 |
$58K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,235 |
479 |
$57K |
| 72193 |
|
191 |
132 |
$57K |
| 58558 |
|
33 |
26 |
$57K |
| 29581 |
|
399 |
144 |
$55K |
| 85027 |
|
20,067 |
12,666 |
$55K |
| 83690 |
|
41,025 |
34,820 |
$55K |
| 73610 |
|
5,107 |
4,260 |
$54K |
| 97161 |
|
1,093 |
805 |
$53K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
10,985 |
9,275 |
$52K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
65,452 |
49,904 |
$52K |
| 82330 |
|
30,472 |
25,879 |
$52K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,968 |
1,192 |
$51K |
| 74018 |
|
2,479 |
2,050 |
$50K |
| 29823 |
|
214 |
150 |
$50K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,605 |
3,263 |
$49K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,809 |
7,843 |
$49K |
| 73502 |
|
2,897 |
2,380 |
$49K |
| 72040 |
|
1,046 |
872 |
$48K |
| 97165 |
|
773 |
606 |
$45K |
| 83050 |
|
12,240 |
10,013 |
$44K |
| 85610 |
|
14,221 |
10,573 |
$44K |
| 73110 |
|
3,166 |
2,630 |
$44K |
| 81003 |
|
40,992 |
36,068 |
$44K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
55,689 |
47,090 |
$44K |
| 20985 |
|
276 |
192 |
$42K |
| 96368 |
|
1,152 |
754 |
$41K |
| 77062 |
|
861 |
760 |
$41K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
19,981 |
11,711 |
$41K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
45 |
13 |
$41K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
16,692 |
11,431 |
$41K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
52,796 |
41,104 |
$39K |
| 76770 |
|
223 |
190 |
$39K |
| 96402 |
|
551 |
451 |
$39K |
| 93880 |
|
485 |
439 |
$39K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
10,905 |
9,130 |
$38K |
| 87081 |
|
15,239 |
13,492 |
$38K |
| 72072 |
|
1,256 |
1,073 |
$38K |
| 72192 |
|
439 |
373 |
$37K |
| J3535 |
Drug administered through a metered dose inhaler |
3,688 |
2,633 |
$37K |
| 99152 |
|
993 |
747 |
$35K |
| 93296 |
|
1,646 |
1,569 |
$33K |
| 94729 |
|
715 |
635 |
$32K |
| 77061 |
|
693 |
614 |
$32K |
| 81025 |
|
15,624 |
14,198 |
$32K |
| 86901 |
|
8,903 |
7,075 |
$30K |
| 77080 |
|
330 |
296 |
$29K |
| 86923 |
|
869 |
630 |
$29K |
| 72146 |
|
235 |
190 |
$29K |
| 96417 |
|
1,424 |
742 |
$29K |
| 84443 |
Thyroid stimulating hormone (TSH) |
10,760 |
8,858 |
$28K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,699 |
7,273 |
$28K |
| 82803 |
|
13,328 |
11,297 |
$27K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
413 |
193 |
$27K |
| 93308 |
|
86 |
71 |
$27K |
| 82375 |
|
12,274 |
10,046 |
$26K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
671 |
264 |
$26K |
| 76981 |
|
338 |
315 |
$26K |
| 72110 |
|
318 |
301 |
$26K |
| 73562 |
|
311 |
292 |
$26K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
299 |
164 |
$25K |
| 82947 |
|
71,014 |
61,248 |
$24K |
| 88341 |
|
411 |
320 |
$24K |
| 87040 |
|
2,456 |
1,793 |
$24K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
27 |
24 |
$24K |
| 85379 |
|
6,585 |
5,326 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,937 |
3,145 |
$23K |
| J2704 |
Injection, propofol, 10 mg |
17,440 |
13,225 |
$23K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
12,684 |
5,338 |
$22K |
| 84702 |
|
7,434 |
5,825 |
$22K |
| 83735 |
|
9,404 |
5,992 |
$22K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
29 |
25 |
$22K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
19,889 |
13,906 |
$21K |
| 73080 |
|
1,815 |
1,531 |
$21K |
| 94726 |
|
364 |
331 |
$21K |
| 96416 |
|
242 |
116 |
$21K |
| 97163 |
|
551 |
429 |
$20K |
| J1815 |
Injection, insulin, per 5 units |
5,364 |
2,355 |
$20K |
| 82150 |
|
13,258 |
10,908 |
$20K |
| 87077 |
|
4,747 |
3,829 |
$20K |
| 76942 |
|
1,076 |
825 |
$20K |
| 82565 |
|
52,119 |
45,075 |
$20K |
| 73590 |
|
2,015 |
1,642 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21,942 |
19,524 |
$19K |
| 88304 |
|
1,025 |
809 |
$19K |
| 99153 |
Mod sedat endo service >5yrs |
645 |
487 |
$18K |
| 86140 |
|
2,857 |
2,252 |
$18K |
| 92523 |
|
1,074 |
817 |
$18K |
| 87070 |
|
2,214 |
1,729 |
$17K |
| 94727 |
|
293 |
254 |
$17K |
| 12013 |
|
123 |
93 |
$17K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
416 |
387 |
$17K |
| 23472 |
|
14 |
12 |
$16K |
| 80076 |
|
7,480 |
6,034 |
$15K |
| 74178 |
|
48 |
41 |
$15K |
| 72120 |
|
218 |
189 |
$15K |
| 93990 |
|
291 |
271 |
$15K |
| 71101 |
|
1,284 |
1,064 |
$15K |
| 82977 |
|
14,610 |
12,108 |
$14K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
145 |
125 |
$14K |
| 84520 |
|
44,277 |
38,048 |
$14K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,964 |
10,856 |
$14K |
| 36416 |
|
2,377 |
1,587 |
$13K |
| J1750 |
Injection, iron dextran, 50 mg |
200 |
94 |
$13K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
98 |
87 |
$13K |
| 85730 |
|
3,839 |
3,055 |
$13K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
12,180 |
9,134 |
$13K |
| 87186 |
|
4,254 |
3,445 |
$13K |
| 82607 |
|
1,388 |
1,072 |
$13K |
| 76870 |
|
743 |
605 |
$13K |
| 72070 |
|
357 |
290 |
$12K |
| 77066 |
Tomosynthesis, mammo |
937 |
830 |
$12K |
| 77065 |
Tomosynthesis, mammo |
797 |
693 |
$12K |
| 82728 |
|
1,503 |
1,164 |
$12K |
| 77336 |
|
143 |
60 |
$12K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
851 |
639 |
$12K |
| 73090 |
|
1,253 |
1,025 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
11,490 |
7,818 |
$11K |
| 73701 |
|
36 |
26 |
$11K |
| 87210 |
|
3,053 |
2,509 |
$11K |
| 31500 |
|
37 |
24 |
$11K |
| 29125 |
|
1,034 |
879 |
$10K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
800 |
365 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,416 |
4,414 |
$10K |
| 88173 |
|
209 |
156 |
$10K |
| 76377 |
|
907 |
748 |
$9K |
| 87154 |
|
70 |
42 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,041 |
858 |
$9K |
| 84132 |
|
32,102 |
27,131 |
$9K |
| 72170 |
|
1,008 |
799 |
$9K |
| 73552 |
|
977 |
785 |
$9K |
| 97167 |
|
121 |
105 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,731 |
3,028 |
$9K |
| 92950 |
|
46 |
34 |
$8K |
| 84295 |
|
31,417 |
26,651 |
$8K |
| 80143 |
|
2,036 |
1,601 |
$8K |
| 82040 |
|
13,859 |
11,460 |
$8K |
| J1453 |
Injection, fosaprepitant, 1 mg |
518 |
276 |
$8K |
| 87205 |
|
2,562 |
1,975 |
$8K |
| 73200 |
|
80 |
67 |
$8K |
| 85007 |
|
2,188 |
1,574 |
$8K |
| 93356 |
|
144 |
114 |
$8K |
| 72158 |
|
35 |
26 |
$8K |
| J9045 |
Injection, carboplatin, 50 mg |
732 |
367 |
$8K |
| 85018 |
|
14,515 |
11,550 |
$8K |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
997 |
481 |
$8K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13,192 |
9,623 |
$7K |
| 84100 |
|
3,592 |
2,278 |
$7K |
| 73060 |
|
837 |
671 |
$7K |
| 83540 |
|
1,480 |
1,141 |
$7K |
| 94010 |
|
53 |
51 |
$7K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,615 |
860 |
$7K |
| 80179 |
|
1,971 |
1,567 |
$7K |
| 82746 |
|
1,297 |
1,006 |
$7K |
| 29515 |
|
367 |
285 |
$7K |
| 76882 |
|
50 |
43 |
$7K |
| 80069 |
|
1,258 |
674 |
$7K |
| 87075 |
|
1,330 |
1,023 |
$7K |
| 85014 |
|
7,681 |
6,705 |
$7K |
| 82435 |
|
20,882 |
17,250 |
$6K |
| C1769 |
Guide wire |
1,188 |
890 |
$6K |
| 85652 |
|
2,829 |
2,259 |
$6K |
| 80061 |
Lipid panel |
1,107 |
850 |
$6K |
| 72156 |
|
52 |
37 |
$6K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
29 |
27 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
8,493 |
6,457 |
$6K |
| 88172 |
|
138 |
104 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
20 |
16 |
$6K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,011 |
461 |
$5K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,677 |
1,651 |
$5K |
| 83550 |
|
1,466 |
1,130 |
$5K |
| 73201 |
|
18 |
14 |
$5K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,021 |
1,436 |
$5K |
| 84439 |
|
1,126 |
876 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,878 |
2,883 |
$5K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,478 |
602 |
$5K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
21 |
12 |
$5K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
518 |
289 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
14,920 |
7,513 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,506 |
1,590 |
$4K |
| 84460 |
|
13,546 |
11,177 |
$4K |
| 84450 |
|
13,473 |
11,114 |
$4K |
| 51701 |
|
481 |
378 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
953 |
713 |
$4K |
| 84155 |
|
13,271 |
10,931 |
$4K |
| 82247 |
|
13,094 |
10,771 |
$4K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
130 |
57 |
$4K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,919 |
1,564 |
$4K |
| 74022 |
|
325 |
263 |
$4K |
| 97802 |
|
35 |
34 |
$4K |
| 84075 |
|
13,150 |
10,823 |
$4K |
| 86703 |
|
664 |
521 |
$4K |
| 87807 |
|
829 |
718 |
$4K |
| 80329 |
|
272 |
251 |
$4K |
| J1953 |
Injection, levetiracetam, 10 mg |
692 |
477 |
$4K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,463 |
999 |
$4K |
| 77002 |
|
31 |
26 |
$4K |
| 88342 |
|
720 |
557 |
$4K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,832 |
1,027 |
$4K |
| 82010 |
|
1,574 |
1,138 |
$3K |
| 87653 |
|
424 |
338 |
$3K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,968 |
1,183 |
$3K |
| J3360 |
Injection, diazepam, up to 5 mg |
1,117 |
822 |
$3K |
| 76937 |
|
163 |
143 |
$3K |
| 95972 |
|
17 |
13 |
$3K |
| 63685 |
|
16 |
13 |
$3K |
| 15853 |
|
473 |
431 |
$3K |
| J3489 |
Injection, zoledronic acid, 1 mg |
255 |
202 |
$3K |
| 87147 |
|
1,039 |
835 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
723 |
618 |
$3K |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
272 |
180 |
$3K |
| 93325 |
|
38 |
24 |
$3K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,019 |
549 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
890 |
764 |
$3K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
5,122 |
3,098 |
$3K |
| 76775 |
|
18 |
17 |
$3K |
| 74280 |
|
12 |
12 |
$3K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,598 |
1,069 |
$3K |
| 87529 |
|
300 |
247 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,840 |
2,097 |
$3K |
| 82550 |
|
1,219 |
862 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,362 |
1,697 |
$2K |
| 86308 |
|
654 |
516 |
$2K |
| J1790 |
Injection, droperidol, up to 5 mg |
2,217 |
1,627 |
$2K |
| 83615 |
|
1,221 |
891 |
$2K |
| 78306 |
|
13 |
12 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,668 |
1,145 |
$2K |
| 86803 |
|
532 |
419 |
$2K |
| 87340 |
|
678 |
499 |
$2K |
| 16020 |
|
34 |
27 |
$2K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
68 |
53 |
$2K |
| 86870 |
|
47 |
37 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,077 |
758 |
$2K |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,039 |
439 |
$2K |
| 86780 |
|
545 |
423 |
$2K |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
613 |
429 |
$2K |
| 72220 |
|
124 |
106 |
$2K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
816 |
532 |
$2K |
| 80177 |
|
412 |
324 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,534 |
839 |
$2K |
| 84134 |
|
80 |
75 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,876 |
1,295 |
$2K |
| 69209 |
|
357 |
302 |
$2K |
| 82570 |
|
820 |
613 |
$2K |
| 96523 |
|
22 |
13 |
$1K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
16 |
12 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,468 |
1,041 |
$1K |
| 88300 |
|
170 |
121 |
$1K |
| 87206 |
|
133 |
95 |
$1K |
| J7999 |
Compounded drug, not otherwise classified |
1,113 |
774 |
$1K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
275 |
209 |
$1K |
| 88302 |
|
45 |
26 |
$1K |
| 82140 |
|
523 |
391 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
806 |
784 |
$1K |
| 87102 |
|
69 |
41 |
$1K |
| J1836 |
Injection, metronidazole, 10 mg |
815 |
456 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
870 |
718 |
$1K |
| 84550 |
|
965 |
719 |
$1K |
| 86592 |
|
545 |
433 |
$1K |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
15 |
12 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,262 |
1,118 |
$1K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
804 |
692 |
$1K |
| 73522 |
|
59 |
53 |
$1K |
| 80074 |
|
150 |
113 |
$1K |
| 84156 |
|
750 |
527 |
$1K |
| 85384 |
|
514 |
381 |
$1K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
46 |
45 |
$1K |
| 87176 |
|
467 |
369 |
$1K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
3,167 |
2,747 |
$1K |
| 93978 |
|
14 |
13 |
$999.54 |
| 92610 |
|
64 |
45 |
$915.69 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
83 |
38 |
$884.22 |
| J0703 |
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
153 |
63 |
$867.26 |
| 87116 |
|
45 |
25 |
$864.00 |
| 93298 |
|
160 |
157 |
$846.53 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
926 |
693 |
$796.60 |
| 80164 |
|
312 |
245 |
$773.91 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,022 |
874 |
$768.24 |
| J0456 |
Injection, azithromycin, 500 mg |
748 |
451 |
$766.27 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
712 |
672 |
$748.85 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
8,339 |
5,919 |
$734.40 |
| 96401 |
|
91 |
37 |
$726.31 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1,872 |
1,660 |
$724.98 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
914 |
510 |
$715.08 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,448 |
706 |
$699.92 |
| 87420 |
|
186 |
168 |
$656.63 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
621 |
463 |
$588.06 |
| 85045 |
|
361 |
212 |
$532.41 |
| C1729 |
Catheter, drainage |
178 |
121 |
$512.10 |
| 82784 |
|
512 |
416 |
$504.39 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
450 |
359 |
$494.43 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
77 |
49 |
$490.17 |
| 73020 |
|
69 |
56 |
$480.84 |
| 99195 |
|
12 |
12 |
$456.20 |
| 84145 |
|
61 |
42 |
$453.92 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
520 |
403 |
$443.29 |
| 73000 |
|
42 |
39 |
$431.17 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
858 |
727 |
$429.35 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
338 |
201 |
$410.86 |
| 73600 |
|
16 |
13 |
$400.91 |
| 87449 |
|
56 |
43 |
$386.82 |
| 29105 |
|
30 |
25 |
$384.99 |
| G0390 |
Trauma response team associated with hospital critical care service |
32 |
30 |
$352.61 |
| 73120 |
|
20 |
19 |
$351.71 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
172 |
116 |
$346.81 |
| 83521 |
|
12 |
12 |
$316.07 |
| 90686 |
|
23 |
22 |
$308.05 |
| 86880 |
|
13 |
12 |
$307.77 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
24 |
14 |
$300.37 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
33 |
26 |
$297.03 |
| 73100 |
|
18 |
13 |
$289.53 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
240 |
174 |
$289.22 |
| 70360 |
|
49 |
38 |
$269.57 |
| 86706 |
|
49 |
39 |
$261.45 |
| 72020 |
|
57 |
51 |
$248.22 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
13 |
$238.07 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
355 |
189 |
$236.88 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
205 |
149 |
$231.33 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
63 |
27 |
$175.36 |
| 87641 |
|
14 |
12 |
$164.86 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
34 |
14 |
$162.10 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
120 |
71 |
$161.43 |
| 86334 |
|
16 |
14 |
$158.71 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
41 |
17 |
$147.86 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
207 |
170 |
$145.50 |
| 84165 |
|
17 |
12 |
$144.56 |
| 36410 |
|
13 |
13 |
$141.07 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
324 |
156 |
$131.40 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
228 |
138 |
$130.79 |
| 81002 |
|
89 |
67 |
$124.20 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
48 |
26 |
$108.30 |
| J9267 |
Injection, paclitaxel, 1 mg |
568 |
228 |
$93.15 |
| J7510 |
Prednisolone oral, per 5 mg |
442 |
356 |
$81.29 |
| 82310 |
|
29 |
26 |
$74.78 |
| 84153 |
|
12 |
12 |
$59.82 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
22 |
12 |
$51.12 |
| 96411 |
|
497 |
273 |
$40.28 |
| J9190 |
Injection, fluorouracil, 500 mg |
489 |
129 |
$26.55 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
17 |
13 |
$16.40 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
169 |
154 |
$12.16 |
| 89051 |
|
14 |
13 |
$11.73 |
| J3590 |
Unclassified biologics |
21 |
14 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
70 |
62 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
162 |
140 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
21 |
12 |
$0.00 |
| 88177 |
|
23 |
14 |
$0.00 |
| 99459 |
|
27 |
21 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
17 |
12 |
$0.00 |
| C1776 |
Joint device (implantable) |
226 |
177 |
$0.00 |
| 82365 |
|
19 |
12 |
$0.00 |
| C8937 |
Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) |
16 |
12 |
$0.00 |
| 87076 |
|
14 |
12 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
29 |
24 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
13 |
12 |
$0.00 |